Charles River Laboratories International CRL
NYSE CRL
$304.40 +5.38 (+1.80%)
As of: Oct 14, 2026 · 2:08 PM EDT

Charles River Laboratories International (CRL) Non Operating Interest Expenses (2009 - 2026)

Updated

Charles River Laboratories International's Non Operating Interest Expenses was $30.34 million in Q2 2026, up 1.2% from $29.97 million a year earlier and up 13.5% from the prior quarter.

Analysis

Charles River Laboratories International (CRL) Non Operating Interest Expenses (2009 - 2026) Analysis & Trends

On a trailing twelve-month basis, Charles River Laboratories International's Non Operating Interest Expenses was $106.26 million through Jun 27, 2026, down 8.7% year-over-year; for FY2025, it was $107.03 million, down 15.3% from FY2024.

  • Non Operating Interest Expenses shows a five-year compound annual growth rate of 4.4% (FY2020 to FY2025).
  • In earlier years, Non Operating Interest Expenses was $126.29 million in FY2024 (-7.6%), $136.71 million in FY2023 (+130.6%), $59.29 million in FY2022 (-19.8%) and $73.91 million in FY2021 (-14.5%).
  • The Q2 2026 figure marks the highest quarterly Non Operating Interest Expenses since Q2 2024.
  • Compared with a year earlier, Non Operating Interest Expenses was higher in 1 of the last eight quarters, with an average decline of 11.2%.
  • The best year-over-year quarter for Non Operating Interest Expenses over five years was Q2 2023 (growth of 846.4%); the worst was Q2 2022 (a decline of 77.1%).
  • Per Business Quant data, CRL's Non Operating Interest Expenses in the three quarters before Q2 2026 was $26.74 million (Q1 2026), $23.78 million (Q4 2025) and $25.4 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Iqvia Holdings 43.61 Bn 35.31 Bn 1.44 Bn 197.00 Mn
2 Medpace Holdings 17.34 Bn 15.40 Bn 201.64 Mn -
3 Charles River Laboratories International 14.63 Bn 13.82 Bn 363.37 Mn 30.34 Mn
4 Icon 13.16 Bn 10.27 Bn 479.29 Mn 48.79 Mn
5 Fortrea Holdings 2.02 Bn 1.40 Bn 139.20 Mn -
6 Ginkgo Bioworks Holdings 723.40 Mn -38.68 Mn 18.44 Mn -
7 Evotec SE 502.55 Mn -1.11 Bn - -
8 Champions Oncology 66.57 Mn 41.65 Mn 7.70 Mn -
9 MindWalk Holdings 63.08 Mn 26.73 Mn 1.61 Mn -
10 Natural Alternatives International 6.81 Mn -21.27 Mn 1.73 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 27, 2026 30.34 Mn
Mar 28, 2026 26.74 Mn
Dec 27, 2025 23.78 Mn
Sep 27, 2025 25.40 Mn
Jun 28, 2025 29.97 Mn
Mar 29, 2025 27.88 Mn
Dec 28, 2024 28.23 Mn
Sep 28, 2024 30.28 Mn
Jun 29, 2024 32.77 Mn
Mar 30, 2024 35.00 Mn
Dec 30, 2023 33.54 Mn
Sep 30, 2023 33.74 Mn
Jul 1, 2023 35.04 Mn
Apr 1, 2023 34.38 Mn
Dec 31, 2022 34.78 Mn
Sep 24, 2022 11.38 Mn
Jun 25, 2022 3.70 Mn
Mar 26, 2022 9.43 Mn
Dec 25, 2021 11.55 Mn
Sep 25, 2021 16.46 Mn
API Access

Charles River Laboratories International Non Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=CRL&period=max&api_key=YOUR_API_KEY